Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation

Volume: 8, Issue: 4, Pages: 2866 - 2875
Published: May 13, 2021
Abstract
Improved cancer survivorship has led to a higher number of anthracycline-induced cardiomyopathy patients with end-stage heart failure. We hypothesize that outcomes following continuous-flow LVAD (CF-LVAD) implantation in those with anthracycline-induced cardiomyopathy are comparable with other aetiologies of cardiomyopathy.Using the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) from 2008 to 2017, we identified...
Paper Details
Title
Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation
Published Date
May 13, 2021
Volume
8
Issue
4
Pages
2866 - 2875
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.